Bank Of America Corp Inmune Bio, Inc. Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 30,393 shares of INMB stock, worth $225,212. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,393
Previous 30,449
0.18%
Holding current value
$225,212
Previous $142,000
66.9%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding INMB
# of Institutions
91Shares Held
6.87MCall Options Held
202KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$6.41 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA827KShares$6.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$6.02 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.42 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL382KShares$2.83 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $133M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...